Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FBLG
#5033
FibroBiologics, Inc. Common Stock
1.4
1
USD
+2.92%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.92%
Monthly Change
+340.63%
6 month change
+235.71%
Year Change
+41.00%
Previous Close
1.3
7
Open
1.4
1
Bid
Ask
Low
1.4
1
High
1.4
1
Volume
5
Markets
US Stock Market
Healthcare
FBLG
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2023
2024
2025
TTM
Cash from operating activities
-6.4 M
-11.9 M
-16.39 M
-16.39 M
Cash from investing activities
-495 K
-184 K
-262 K
-262 K
Cash from financing activities
13.79 M
16.91 M
7.57 M
7.57 M
Free cash flow
-6.9 M
-12.09 M
-16.66 M
-16.66 M
News
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11%
Upcoming Stock Splits This Week (March 30 to April 2) – Stay Invested - TipRanks.com
FibroBiologics completes site onboarding for diabetic ulcer trial
FibroBiologics receives patent for osteoporosis cell therapy
H.C. Wainwright cuts FibroBiologics stock price target to $4
FibroBiologics shareholders approve reverse stock split and warrant share issuances
FibroBiologics gets Nasdaq extension to meet listing rules
FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026
FibroBiologics reports positive results for disc degeneration therapy
FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal
FibroBiologics stock maintains Buy rating at H.C. Wainwright on psoriasis IND filing
FibroBiologics files IND application for psoriasis treatment